Selected research
Market Analysis & Forecast
Global Pet Biopsy Services Market Analysis and Forecast 2026-2032
Market perspective
The global Pet Biopsy Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Pet Biopsy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Pet Biopsy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Pet Biopsy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Pet Biopsy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Pet Biopsy Services include Small Door, VDx Diagnostics, MSU VDL, VCA Animal Hospitals, Iowa State University College of Veterinary Medicine, IDEXX, Vetwest, The Animal Medical Center and Innovative Vet Path, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pet Biopsy Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Pet Biopsy Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Pet Biopsy Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Biopsy Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pet Biopsy Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pet Biopsy Services revenue, projected growth trends, production technology, application and end-user industry.
Pet Biopsy Services Segment by Company
Small Door
VDx Diagnostics
MSU VDL
VCA Animal Hospitals
Iowa State University College of Veterinary Medicine
IDEXX
Vetwest
The Animal Medical Center
Innovative Vet Path
Mars Veterinary Health
AniCura
VetPartners
National Veterinary Associates
Pet Biopsy Services Segment by Type
Needle Biopsy
Punch Biopsy
Wedge Biopsy
Excisional Biopsy
Pet Biopsy Services Segment by Application
Canine biopsy services
Feline biopsy services
Others
Pet Biopsy Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Biopsy Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Biopsy Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Biopsy Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pet Biopsy Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pet Biopsy Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Biopsy Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Needle Biopsy
- Punch Biopsy
- Wedge Biopsy
- Excisional Biopsy
Applications
- Canine biopsy services
- Feline biopsy services
- Others
Companies covered
- Small Door
- VDx Diagnostics
- MSU VDL
- VCA Animal Hospitals
- Iowa State University College of Veterinary Medicine
- IDEXX
- Vetwest
- The Animal Medical Center
- Innovative Vet Path
- Mars Veterinary Health
- AniCura
- VetPartners
- National Veterinary Associates
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Pet Biopsy Services Market by Type
- 1.2.1 Global Pet Biopsy Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Needle Biopsy
- 1.2.3 Punch Biopsy
- 1.2.4 Wedge Biopsy
- 1.2.5 Excisional Biopsy
- 1.3 Pet Biopsy Services Market by Application
- 1.3.1 Global Pet Biopsy Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Canine biopsy services
- 1.3.3 Feline biopsy services
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pet Biopsy Services Market Dynamics
- 2.1 Pet Biopsy Services Industry Trends
- 2.2 Pet Biopsy Services Industry Drivers
- 2.3 Pet Biopsy Services Industry Opportunities and Challenges
- 2.4 Pet Biopsy Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Pet Biopsy Services Market Perspective (2021-2032)
- 3.2 Global Pet Biopsy Services Growth Trends by Region
- 3.2.1 Global Pet Biopsy Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Pet Biopsy Services Market Size by Region (2021-2026)
- 3.2.3 Global Pet Biopsy Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Pet Biopsy Services Revenue by Players
- 4.1.1 Global Pet Biopsy Services Revenue by Players (2021-2026)
- 4.1.2 Global Pet Biopsy Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Pet Biopsy Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Pet Biopsy Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Pet Biopsy Services Key Players Headquarters & Area Served
- 4.4 Global Pet Biopsy Services Players, Product Type & Application
- 4.5 Global Pet Biopsy Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Pet Biopsy Services Market CR5 and HHI
- 4.6.3 2025 Pet Biopsy Services Tier 1, Tier 2, and Tier 3
5 Pet Biopsy Services Market Size by Type
- 5.1 Global Pet Biopsy Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Pet Biopsy Services Revenue by Type (2021-2032)
- 5.3 Global Pet Biopsy Services Revenue Market Share by Type (2021-2032)
6 Pet Biopsy Services Market Size by Application
- 6.1 Global Pet Biopsy Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Pet Biopsy Services Revenue by Application (2021-2032)
- 6.3 Global Pet Biopsy Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Small Door
- 7.1.1 Small Door Company Information
- 7.1.2 Small Door Business Overview
- 7.1.3 Small Door Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Small Door Pet Biopsy Services Product Portfolio
- 7.1.5 Small Door Recent Developments
- 7.2 VDx Diagnostics
- 7.2.1 VDx Diagnostics Company Information
- 7.2.2 VDx Diagnostics Business Overview
- 7.2.3 VDx Diagnostics Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.2.4 VDx Diagnostics Pet Biopsy Services Product Portfolio
- 7.2.5 VDx Diagnostics Recent Developments
- 7.3 MSU VDL
- 7.3.1 MSU VDL Company Information
- 7.3.2 MSU VDL Business Overview
- 7.3.3 MSU VDL Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.3.4 MSU VDL Pet Biopsy Services Product Portfolio
- 7.3.5 MSU VDL Recent Developments
- 7.4 VCA Animal Hospitals
- 7.4.1 VCA Animal Hospitals Company Information
- 7.4.2 VCA Animal Hospitals Business Overview
- 7.4.3 VCA Animal Hospitals Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.4.4 VCA Animal Hospitals Pet Biopsy Services Product Portfolio
- 7.4.5 VCA Animal Hospitals Recent Developments
- 7.5 Iowa State University College of Veterinary Medicine
- 7.5.1 Iowa State University College of Veterinary Medicine Company Information
- 7.5.2 Iowa State University College of Veterinary Medicine Business Overview
- 7.5.3 Iowa State University College of Veterinary Medicine Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Iowa State University College of Veterinary Medicine Pet Biopsy Services Product Portfolio
- 7.5.5 Iowa State University College of Veterinary Medicine Recent Developments
- 7.6 IDEXX
- 7.6.1 IDEXX Company Information
- 7.6.2 IDEXX Business Overview
- 7.6.3 IDEXX Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.6.4 IDEXX Pet Biopsy Services Product Portfolio
- 7.6.5 IDEXX Recent Developments
- 7.7 Vetwest
- 7.7.1 Vetwest Company Information
- 7.7.2 Vetwest Business Overview
- 7.7.3 Vetwest Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Vetwest Pet Biopsy Services Product Portfolio
- 7.7.5 Vetwest Recent Developments
- 7.8 The Animal Medical Center
- 7.8.1 The Animal Medical Center Company Information
- 7.8.2 The Animal Medical Center Business Overview
- 7.8.3 The Animal Medical Center Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.8.4 The Animal Medical Center Pet Biopsy Services Product Portfolio
- 7.8.5 The Animal Medical Center Recent Developments
- 7.9 Innovative Vet Path
- 7.9.1 Innovative Vet Path Company Information
- 7.9.2 Innovative Vet Path Business Overview
- 7.9.3 Innovative Vet Path Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Innovative Vet Path Pet Biopsy Services Product Portfolio
- 7.9.5 Innovative Vet Path Recent Developments
- 7.10 Mars Veterinary Health
- 7.10.1 Mars Veterinary Health Company Information
- 7.10.2 Mars Veterinary Health Business Overview
- 7.10.3 Mars Veterinary Health Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Mars Veterinary Health Pet Biopsy Services Product Portfolio
- 7.10.5 Mars Veterinary Health Recent Developments
- 7.11 AniCura
- 7.11.1 AniCura Company Information
- 7.11.2 AniCura Business Overview
- 7.11.3 AniCura Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.11.4 AniCura Pet Biopsy Services Product Portfolio
- 7.11.5 AniCura Recent Developments
- 7.12 VetPartners
- 7.12.1 VetPartners Company Information
- 7.12.2 VetPartners Business Overview
- 7.12.3 VetPartners Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.12.4 VetPartners Pet Biopsy Services Product Portfolio
- 7.12.5 VetPartners Recent Developments
- 7.13 National Veterinary Associates
- 7.13.1 National Veterinary Associates Company Information
- 7.13.2 National Veterinary Associates Business Overview
- 7.13.3 National Veterinary Associates Pet Biopsy Services Revenue and Gross Margin (2021-2026)
- 7.13.4 National Veterinary Associates Pet Biopsy Services Product Portfolio
- 7.13.5 National Veterinary Associates Recent Developments
8 North America
- 8.1 North America Pet Biopsy Services Revenue (2021-2032)
- 8.2 North America Pet Biopsy Services Revenue by Type (2021-2032)
- 8.2.1 North America Pet Biopsy Services Revenue by Type (2021-2026)
- 8.2.2 North America Pet Biopsy Services Revenue by Type (2027-2032)
- 8.3 North America Pet Biopsy Services Revenue Share by Type (2021-2032)
- 8.4 North America Pet Biopsy Services Revenue by Application (2021-2032)
- 8.4.1 North America Pet Biopsy Services Revenue by Application (2021-2026)
- 8.4.2 North America Pet Biopsy Services Revenue by Application (2027-2032)
- 8.5 North America Pet Biopsy Services Revenue Share by Application (2021-2032)
- 8.6 North America Pet Biopsy Services Revenue by Country
- 8.6.1 North America Pet Biopsy Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Pet Biopsy Services Revenue by Country (2021-2026)
- 8.6.3 North America Pet Biopsy Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Pet Biopsy Services Revenue (2021-2032)
- 9.2 Europe Pet Biopsy Services Revenue by Type (2021-2032)
- 9.2.1 Europe Pet Biopsy Services Revenue by Type (2021-2026)
- 9.2.2 Europe Pet Biopsy Services Revenue by Type (2027-2032)
- 9.3 Europe Pet Biopsy Services Revenue Share by Type (2021-2032)
- 9.4 Europe Pet Biopsy Services Revenue by Application (2021-2032)
- 9.4.1 Europe Pet Biopsy Services Revenue by Application (2021-2026)
- 9.4.2 Europe Pet Biopsy Services Revenue by Application (2027-2032)
- 9.5 Europe Pet Biopsy Services Revenue Share by Application (2021-2032)
- 9.6 Europe Pet Biopsy Services Revenue by Country
- 9.6.1 Europe Pet Biopsy Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Pet Biopsy Services Revenue by Country (2021-2026)
- 9.6.3 Europe Pet Biopsy Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Pet Biopsy Services Revenue (2021-2032)
- 10.2 China Pet Biopsy Services Revenue by Type (2021-2032)
- 10.2.1 China Pet Biopsy Services Revenue by Type (2021-2026)
- 10.2.2 China Pet Biopsy Services Revenue by Type (2027-2032)
- 10.3 China Pet Biopsy Services Revenue Share by Type (2021-2032)
- 10.4 China Pet Biopsy Services Revenue by Application (2021-2032)
- 10.4.1 China Pet Biopsy Services Revenue by Application (2021-2026)
- 10.4.2 China Pet Biopsy Services Revenue by Application (2027-2032)
- 10.5 China Pet Biopsy Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Pet Biopsy Services Revenue (2021-2032)
- 11.2 Asia Pet Biopsy Services Revenue by Type (2021-2032)
- 11.2.1 Asia Pet Biopsy Services Revenue by Type (2021-2026)
- 11.2.2 Asia Pet Biopsy Services Revenue by Type (2027-2032)
- 11.3 Asia Pet Biopsy Services Revenue Share by Type (2021-2032)
- 11.4 Asia Pet Biopsy Services Revenue by Application (2021-2032)
- 11.4.1 Asia Pet Biopsy Services Revenue by Application (2021-2026)
- 11.4.2 Asia Pet Biopsy Services Revenue by Application (2027-2032)
- 11.5 Asia Pet Biopsy Services Revenue Share by Application (2021-2032)
- 11.6 Asia Pet Biopsy Services Revenue by Country
- 11.6.1 Asia Pet Biopsy Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Pet Biopsy Services Revenue by Country (2021-2026)
- 11.6.3 Asia Pet Biopsy Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Pet Biopsy Services Revenue (2021-2032)
- 12.2 SAMEA Pet Biopsy Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Pet Biopsy Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Pet Biopsy Services Revenue by Type (2027-2032)
- 12.3 SAMEA Pet Biopsy Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Pet Biopsy Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Pet Biopsy Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Pet Biopsy Services Revenue by Application (2027-2032)
- 12.5 SAMEA Pet Biopsy Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Pet Biopsy Services Revenue by Country
- 12.6.1 SAMEA Pet Biopsy Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Pet Biopsy Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Pet Biopsy Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst